GlassScriptPhysician profile
Brian W Holyk
NPI 1013201946
$6,267.34
in general payments reported to CMS, 2019-2025
38 companies · $996 in 2025
The $996 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $453 · 2021: $482 · 2022: $990 · 2023: $1,270 · 2024: $1,362 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,628.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,790.06 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Amgen INC. | $465.89 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $320.05 | 2020-2024 | Jot Dx, Mitraclip, Amplatzer Amulet |
| Inari Medical, INC. | $286.03 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.73 | 2019-2024 | Lifevest |
| Biosense Webster, INC. | $242.71 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.51 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $238.17 | 2019-2025 | |
| Abiomed | $234.45 | 2023-2024 | Impella |
| Stryker Corporation | $227.11 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $222.24 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $180.84 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $176.06 | 2020-2024 | Farxiga |
| Heartflow, INC. | $151.26 | 2022 | |
| Janssen Pharmaceuticals, INC | $146.80 | 2019-2024 | Xarelto |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $131.19 | 2019-2024 | Evkeeza |
| Philips North America LLC | $109.28 | 2023-2025 | (Ck7) Extended Holter, Ecc Solutions |
| Merck Sharp & Dohme LLC | $107.16 | 2021-2024 | Verquvo |
| Cardiovascular Systems INC. | $100.54 | 2019-2021 | |
| Novo Nordisk INC | $86.70 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $81.38 | 2022-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $71.95 | 2019-2020 | |
| Amarin Pharma, INC. | $55.99 | 2019-2020 | |
| Nuwellis, INC. | $45.82 | 2020 | |
| Braemar Manufacturing, LLC | $37.15 | 2019 | |
| Biotronik INC. | $24.98 | 2020 | |
| Cvrx, INC. | $24.82 | 2024 | Barostim Neo System |
| Daiichi Sankyo INC. | $23.64 | 2024 | Injectafer |
| Medtronic, INC. | $21.36 | 2021 | |
| Cleerly, INC. | $20.69 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $20.22 | 2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $19.49 | 2023 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $18.98 | 2023 | Arcalyst |
| Elutia, INC. | $18.18 | 2024 | Ecm Patch,Pouch |
| Terumo Medical Corporation | $18.18 | 2023 | Angio-Seal |
| Kowa Pharmaceuticals America, INC. | $15.76 | 2021 | |
| Astellas Pharma US INC | $12.97 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Holyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.